Demars Financial Group LLC raised its stake in Medical Properties Trust, Inc. (NYSE:MPW - Free Report) by 49.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 321,713 shares of the real estate investment trust's stock after purchasing an additional 105,790 shares during the quarter. Demars Financial Group LLC owned 0.05% of Medical Properties Trust worth $1,940,000 at the end of the most recent reporting period.
A number of other institutional investors have also modified their holdings of the stock. Indie Asset Partners LLC lifted its position in Medical Properties Trust by 16.7% in the fourth quarter. Indie Asset Partners LLC now owns 15,384 shares of the real estate investment trust's stock valued at $61,000 after purchasing an additional 2,204 shares during the period. Sei Investments Co. raised its stake in shares of Medical Properties Trust by 6.6% during the 4th quarter. Sei Investments Co. now owns 39,252 shares of the real estate investment trust's stock worth $155,000 after buying an additional 2,438 shares in the last quarter. Farther Finance Advisors LLC lifted its holdings in shares of Medical Properties Trust by 49.5% in the 1st quarter. Farther Finance Advisors LLC now owns 7,875 shares of the real estate investment trust's stock valued at $47,000 after buying an additional 2,606 shares during the period. Nissay Asset Management Corp Japan ADV lifted its holdings in shares of Medical Properties Trust by 5.6% in the 4th quarter. Nissay Asset Management Corp Japan ADV now owns 49,953 shares of the real estate investment trust's stock valued at $186,000 after buying an additional 2,661 shares during the period. Finally, Atria Wealth Solutions Inc. boosted its stake in shares of Medical Properties Trust by 2.7% in the fourth quarter. Atria Wealth Solutions Inc. now owns 111,490 shares of the real estate investment trust's stock valued at $440,000 after buying an additional 2,948 shares in the last quarter. Institutional investors and hedge funds own 71.79% of the company's stock.
Medical Properties Trust Price Performance
NYSE MPW traded up $0.02 during trading hours on Friday, reaching $4.44. The company's stock had a trading volume of 14,299,928 shares, compared to its average volume of 11,774,294. The company has a debt-to-equity ratio of 1.99, a quick ratio of 3.23 and a current ratio of 3.23. The company's 50-day moving average is $4.93 and its two-hundred day moving average is $4.85. Medical Properties Trust, Inc. has a fifty-two week low of $3.51 and a fifty-two week high of $6.55. The stock has a market cap of $2.66 billion, a PE ratio of -1.60 and a beta of 1.32.
Medical Properties Trust (NYSE:MPW - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The real estate investment trust reported $0.14 EPS for the quarter, missing the consensus estimate of $0.15 by ($0.01). Medical Properties Trust had a negative net margin of 174.35% and a negative return on equity of 31.14%. The business had revenue of $223.80 million during the quarter, compared to analyst estimates of $233.80 million. During the same quarter in the prior year, the company earned $0.24 earnings per share. The firm's revenue for the quarter was down 17.5% compared to the same quarter last year. Analysts forecast that Medical Properties Trust, Inc. will post 0.78 EPS for the current year.
Medical Properties Trust Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Thursday, July 17th. Shareholders of record on Wednesday, June 18th will be given a dividend of $0.08 per share. This represents a $0.32 annualized dividend and a yield of 7.22%. The ex-dividend date is Wednesday, June 18th. Medical Properties Trust's payout ratio is -11.55%.
Analysts Set New Price Targets
A number of equities research analysts have commented on MPW shares. Wall Street Zen raised Medical Properties Trust from a "sell" rating to a "hold" rating in a report on Monday, March 3rd. BNP Paribas upgraded shares of Medical Properties Trust from a "neutral" rating to an "outperform" rating and increased their price target for the company from $5.00 to $9.00 in a report on Wednesday, March 12th. Wells Fargo & Company boosted their price objective on shares of Medical Properties Trust from $4.00 to $5.00 and gave the stock an "underweight" rating in a report on Monday, March 10th. Finally, Royal Bank Of Canada upped their target price on shares of Medical Properties Trust from $4.00 to $5.00 and gave the stock a "sector perform" rating in a research report on Monday, March 10th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $5.75.
View Our Latest Analysis on Medical Properties Trust
Medical Properties Trust Company Profile
(
Free Report)
Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.
Further Reading

Before you consider Medical Properties Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medical Properties Trust wasn't on the list.
While Medical Properties Trust currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.